海寧皮城(002344.SZ):擬以2億元參與投設紅杉基金 其主要關注科技、醫療健康、消費服務等行業的投資機會
格隆匯7月27日丨海寧皮城(002344.SZ)公佈,公司全資子公司海寧中國皮革城投資有限公司(“投資公司”)近日與紅杉資本股權投資管理(天津)有限公司(“紅杉資本”)、杭州紅杉坤鵬管理諮詢合夥企業(有限合夥)(“紅杉坤鵬”)簽訂了《杭州紅杉晟恆股權投資合夥企業(有限合夥)有限合夥協議》,擬共同投資設立“杭州紅杉晟恆股權投資合夥企業(有限合夥)”(“紅杉基金”、“合夥企業”)。投資公司作為紅杉基金有限合夥人,以自有資金出資人民幣2億元。
由於紅杉基金尚處於籌備和募集階段,其他合夥人尚未完全確定,最終合夥人名單及認繳金額等信息以工商部門核准為準。紅杉基金將主要關注科技、醫療健康、消費服務等行業的投資機會,對企業進行權益性投資為主的投資,同時兼顧併購投資機會。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.